Inozyme Pharma
www.inozyme.comWe are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.
Read moreWe are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.
Read moreCountry
State
Massachusetts
City (Headquarters)
Boston
Industry
Employees
11-50
Founded
2016
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President and Chief People Officer
Email ****** @****.comPhone (***) ****-****Vice President , Head of Program Management
Email ****** @****.comPhone (***) ****-****Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****Independant Director and Audit Committee Chair
Email ****** @****.comPhone (***) ****-****
Technologies
(47)